Apresoline and Pomalyst drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Apresoline (hydralazine hydrochloride) and Pomalyst (pomalidomide). Common drug interactions include fatigue among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Apresoline and Pomalyst. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Apresoline?

Apresoline has active ingredients of hydralazine hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 2,475 Apresoline users. Check the latest studies of Apresoline.

What is Pomalyst?

Pomalyst has active ingredients of pomalidomide. eHealthMe is studying from 80,400 Pomalyst users. Check the latest studies of Pomalyst.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

16 people who take Apresoline and Pomalyst together, and have interactions are studied.

Apresoline and Pomalyst drug interactions.

What are the common drug interactions of Apresoline and Pomalyst, by gender? *:

female:

Fatigue (feeling of tiredness)
Adverse drug reaction
Cardiac death
Diarrhoea
Drug hypersensitivity
Influenza
Oral herpes (viral infection of mouth)
Pneumonia

male:

Cardiac failure congestive
Pneumonia
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Pathological fracture (broken bone caused by disease)
Plasmacytoma (neoplasm of plasma cells (usually in bone marrow))
Urinary tract infection
Full blood count decreased
Haemoglobin decreased
Influenza
Diarrhoea

What are the common drug interactions of Apresoline and Pomalyst, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Pneumonia
Dyspnoea (difficult or laboured respiration)
Humerus fracture (injury to the upper arm bone)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Pathological fracture (broken bone caused by disease)
Plasma cell myeloma (cancer that begins in plasma cells)
Plasmacytoma (neoplasm of plasma cells (usually in bone marrow))
Urinary tract infection
Adverse drug reaction
Drug hypersensitivity

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 16 people, 100.00%
Pain: 2 people, 12.50%
Oedema Peripheral (superficial swelling): 2 people, 12.50%
Constipation: 2 people, 12.50%
Anaemia (lack of blood): 2 people, 12.50%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 6.25%
High Blood Cholesterol: 1 person, 6.25%
Herpes Zoster: 1 person, 6.25%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 6.25%
Diarrhea: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Apresoline and Pomalyst?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously